Dr. Michael Rozboril, M.D.
What this data tells you about Dr. Rozboril
Dr. Michael Rozboril is a rheumatology specialist in Gainesville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rozboril performed 88,461 Medicare services across 2,107 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rozboril received a total of $6,779 from 10 pharmaceutical and/or device companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rozboril is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 46253 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 57,200 | $4 | $9 |
| Denosumab injection (Prolia/Xgeva) | 14,220 | $18 | $29 |
| Golimumab infusion (Simponi Aria) | 13,494 | $10 | $28 |
| Office visit, established patient (20-29 min) | 1,283 | $62 | $137 |
| Office visit, established patient (30-39 min) | 426 | $88 | $195 |
| Drug injection, under skin or into muscle | 389 | $11 | $30 |
| Bone density scan (DEXA) | 199 | $37 | $135 |
| Basic metabolic blood panel | 161 | $8 | $47 |
| Complete blood count (CBC) with differential | 142 | $8 | $25 |
| Comprehensive metabolic blood panel | 138 | $10 | $49 |
| Physical therapy exercise, per 15 min | 126 | $19 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 122 | $49 | $100 |
| Manual therapy (hands-on treatment), per 15 min | 77 | $17 | $38 |
| Injection, zoledronic acid, 1 mg | 55 | $7 | $79 |
| C-reactive protein test (inflammation marker) | 39 | $5 | $29 |
| Blood draw (venipuncture) | 38 | $8 | $15 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 33 | $112 | $116 |
| Functional activity therapy | 32 | $28 | $44 |
| Lipid panel (cholesterol and triglycerides) | 30 | $13 | $75 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 27 | $4 | $25 |
| Neuromuscular re-education therapy, per 15 min | 26 | $24 | $43 |
| Thyroid stimulating hormone (TSH) test | 24 | $16 | $94 |
| Vitamin D level test | 22 | $29 | $79 |
| Hemoglobin A1c test (diabetes monitoring) | 18 | $10 | $54 |
| Joint injection, major joint | 17 | $54 | $132 |
| Flu vaccine, high-dose | 16 | $72 | $80 |
| New patient office visit (45-59 min) | 16 | $127 | $254 |
| Flu vaccine administration | 16 | $29 | $30 |
| Acute hepatitis panel | 15 | $47 | $145 |
| Drug screening test | 13 | $61 | $120 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 12 | $31 | $46 |
| Vitamin B-12 level test | 12 | $15 | $84 |
| Uric acid level test | 12 | $4 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $23 | $57 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rozboril is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), with speaking/promotional industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rozboril experienced with certolizumab injection (cimzia)?
Does Dr. Rozboril receive payments from pharmaceutical companies?
How do Dr. Rozboril's costs compare to other rheumatologists in Gainesville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology